Xtant Medical Holdings (XTNT) Return on Capital Employed Growth (1y) (2012 - 2025)
Xtant Medical Holdings (XTNT) Return on Capital Employed Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 658.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 125.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -3,185.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 5,454.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,454.00 |
| Sep 30, 2025 | 3,117.00 |
| Jun 30, 2025 | 2,052.00 |
| Mar 31, 2025 | 703.00 |
| Dec 31, 2024 | -316.00 |
| Sep 30, 2024 | -778.00 |
| Jun 30, 2024 | -654.00 |
| Mar 31, 2024 | -398.00 |
| Dec 31, 2023 | 108.00 |
| Sep 30, 2023 | 189.00 |
| Jun 30, 2023 | 185.00 |
| Mar 31, 2023 | -131.00 |
| Dec 31, 2022 | -702.00 |
| Sep 30, 2022 | -1,254.00 |
| Jun 30, 2022 | -1,688.00 |
| Mar 31, 2022 | -1,563.00 |
| Dec 31, 2021 | -412.00 |
| Sep 30, 2021 | 41.00 |
| Jun 30, 2021 | 959.00 |
| Mar 31, 2021 | 1,132.00 |